Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075591 · ClinicalTrials.gov registry record · NA
Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia
A NA study of Refractive Error, sponsored by AMO Development.
- Completed
- Registry status
- NA
- Development phase
- 219
- Enrollment target
- 10
- Study locations
NCT04075591 is a NA study of Refractive Error that has completed, run by AMO Development. The registered enrollment target is 219 participants, below the 574-participant average among 5 other Refractive Error trials with a reported enrollment target (62% lower). The trial reports 10 study locations across 9 states.
The verdict
NCT04075591, a NA study of Refractive Error, has completed, sponsored by AMO Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.
Conditions Studied
Interventions
- DEVICE iDesign Refractive Studio with STAR S4 IR® Excimer laser System
Study Locations (10)
Texas
- Berkeley Eye Institute, P.A. - Houston
- Texas Eye & Laser Center - Hurst
California
- Maloney Vision Institute - Los Angeles
Illinois
- Kraff Eye Institute - Chicago
Nevada
- Center for Sight - Las Vegas
New Mexico
- Coleman Vision - Albuquerque
South Dakota
- Vance Thompson Vision - Sioux Falls
Tennessee
- Loden Vision Centers - Goodlettsville
Utah
- Utah Eye Center - Ogden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2019-09-24 |
| Est. Completion | 2025-06-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04075591
The ClinicalTrials.gov registry entry for NCT04075591 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 574-participant average among 5 other Refractive Error trials with a reported enrollment target (62% lower). The listed sponsor is AMO Development, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Refractive Error appearing as the primary indexed condition, and to 1 intervention - of which iDesign Refractive Studio with STAR S4 IR® Excimer laser System is the first listed.
NCT04075591 reports 10 study locations spanning 9 distinct geographic areas - top geographies include Texas, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT04075591 about?
NCT04075591 is a clinical study titled "Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia". This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of...
What is the current status of trial NCT04075591?
This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2019-09-24. Estimated completion is 2025-06-25.
What conditions does trial NCT04075591 study?
This clinical trial studies the following conditions: Refractive Error.
What interventions are being tested in trial NCT04075591?
The interventions under investigation include: iDesign Refractive Studio with STAR S4 IR® Excimer laser System (DEVICE).
Who is sponsoring clinical trial NCT04075591?
This trial is sponsored by AMO Development, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04075591 being conducted?
This trial has 10 study locations across California, Illinois, Nevada, New Mexico, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Error
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
RECRUITING · NA
-
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
COMPLETED · NA
-
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
COMPLETED
-
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
COMPLETED · Phase 4
-
A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITA
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.